Siemens sets stage for Healthineers IPO

Michael Walter | | Radiology Business | Economics

Siemens announced this week it is planning to list its healthcare division, Siemens Healthineers, on the Frankfurt Stock Exchange in Germany sometime in the first half of 2018. The initial public offering (IPO) is expected to take place as early as March.

The IPO is not being viewed as an indication that Siemens is stepping back from healthcare in any way—in fact, it likely means the company is looking to push forward and finalize some acquisitions.

Siemens isn’t talking quite yet about the exact specifics, but a report from Bloomberg suggests it will be “one of the biggest equity offerings ever in Germany” as the company looks to raise more than $12 billion. Sources close to the situation told Reuters that Siemens plans on selling 15 to 20 percent of the Healthineers division overall as a part of this move.

Radiology Business covered the possibility of this move back in January.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers
Congress ditches doc fix in stopgap end-of-year funding bill
Teleradiology provider inks post-acute care deal worth $1.5M annually
US Radiology Specialists affiliate expands into new market
Radiologist rails against insurer’s refusal to cover key interventional service
Blue Cross Blue Shield affiliate rejects MRI contrast coverage, labeling it ‘investigational’

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.